Minerva Neurosciences reported $5.21M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 161.58M 6.63M
Adma Biologics ADMA:US USD 18.97M 24.11M
ALKERMES ALKS:US USD 313M 2.32M
AstraZeneca AZN:LN USD 9.74B 495M
Biocryst Pharmaceuticals BCRX:US USD 93.27M 6.98M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Dynavax Technologies DVAX:US USD 106.34M 21.9M
Eli Lilly And LLY:US USD 5.27B 12.8M
Esperion Therapeutics ESPR:US USD 60.6M 10.61M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
Johnson & Johnson JNJ:US USD 17.97B 211M
Marinus Pharmaceuticals MRNS:US USD 32.44M 6.12M
Merk MRK:US USD 10.97B 1.31B
Minerva Neurosciences NERV:US USD 5.21M 1.76M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Novartis NOVN:VX USD 10.67B 183M
Novavax NVAX:US USD 861.77M 192.88M
Pfizer PFE:US USD 13.23B 2.41B
Roche Holding ROG:VX 20.75B 3.26B
Takeda 4502:JP JPY 897.87B 75.92B
Vanda Pharmaceuticals VNDA:US USD 61.41M 481K